The PQI Podcast

What happens when cancer becomes part of your life—but work doesn't stop?In the Season 8 finale of The PQI Podcast, we sit down with Rebecca Nellis, MPP, Executive Director of Cancer and Careers, for an eye-opening conversation about a part of survivorship that often gets overlooked: navigating work during and after treatment.From the stress of disclosing a diagnosis to managing side effects on the job, cancer survivors face tough questions—often without clear answers. Rebecca shares how Cancer and Careers is changing that by equipping patients, employers, and healthcare providers with tools, empathy, and support.In this episode, you'll hear about:The mission and evolution of Cancer and CareersWhy work can be both a lifeline and a burden for cancer survivorsThe power of identity and purpose throughout the work journey—during and after treatmentReal programs that make a difference—like resume reviews, tech grants, and workplace trainingWhat healthcare providers can do to spot red flags and offer the right kind of helpHow COVID, remote work, and cultural shifts are reshaping survivorship in the workforce Explore more at: www.cancerandcareers.org

With more adults living longer, oncology is facing a critical challenge: how to provide cancer care that reflects the realities of aging. In this episode, Dr. Dale walks us through the creation of SOCARE (Specialized Oncology Care and Research in Elders), a clinic that evaluates patients' physical function, cognitive health, and social environment before treatment begins. This kind of assessment leads to better decisions, fewer complications, and care that aligns with each person's capacity and goals.We also talk about the OASIS program, which extends this approach across disciplines, bringing in nurses, pharmacists, and social workers to create a more coordinated experience for patients. Throughout the conversation, Dr. Dale shares real examples and lessons from the field, showing how geriatric oncology can improve not just outcomes, but the entire care process.Episode Highlights:A fresh look at what defines “fitness” for cancer treatment — and why age alone isn't enoughHow SoCare creates space for longer, more thoughtful patient conversationsPractical examples of tailoring chemotherapy, transplant, and CAR T plans for older adultsInsights into building trust with patients and providers through individualized care Resources & LinksCity of Hope – Center for Cancer and Aging: cityofhope.orgASCO Geriatric Oncology Guidelines: asco.org

In this episode, we're joined by Michael Heimall, President and CEO of the HealthWell Foundation, to talk about the growing importance of financial assistance in oncology and chronic illness care.Michael shares his journey from leading some of the nation's top military and veterans' medical centers to helping patients access critical treatment through HealthWell's innovative funding programs. He reflects on how his personal experience as a caregiver continues to shape his approach to patient-centered leadership.We discuss HealthWell's mission, how their programs are easing financial toxicity, and why care teams—especially in oncology—play such an important role in connecting patients with real support.In this episode:How financial assistance programs are supporting patients beyond the pharmacy counterExpanding access for caregivers and patients managing home-based careWhat oncology teams should know about referrals and fund alertsThe connection between cost, care quality, and treatment outcomes

Melanoma treatment has advanced significantly over the past decade, and it continues to evolve. In this special Melanoma Monday episode, we are joined by Kendra Rodriguez, PharmD, PGY2 Oncology Pharmacy Resident at UW Medical Center / Fred Hutchinson Cancer Center, to explore where we are now in the treatment landscape—and what's on the horizon.Kendra walks through recent data from the NADINA and SWOG S1801 trials, and shares how care teams can start preparing for the shift in management to the neoadjuvant setting. You'll hear what it takes to manage complex therapies for resectable cutaneous melanoma, and how to engage patients through thoughtful communication and collaboration.CE Activity Description:The purpose of this CE activity is to describe the pathophysiology and literature behind the shift of pharmacotherapeutic management to the neoadjuvant setting in resectable cutaneous melanoma. As novel mechanisms have been sought after and approved within this disease state, attention will be given to assess the clinical utility of the first-in-class tumor-infiltrating lymphocyte, lifileucel, in addition to its logistical considerations requiring multidisciplinary coordination.Learning Objectives:Summarize the pathophysiology behind neoadjuvant treatment in cutaneous melanoma and the literature supporting its useDiscuss the novel agent lifileucel for its efficacy in cutaneous melanoma treatment and the logistics related to its useDisclosures:No relevant financial relationships for the following faculty and reviewers:• Kendra Gee-Rodriguez, PharmD• Ginger Blackmon, PharmD• Daisy Doan, PharmDClaim credit: https://www.lecturepanda.com/r/CutaneousMelanoma

Lorlatinib is reshaping first-line treatment for ALK-positive NSCLC—but its distinct side effect profile demands proactive, personalized management. In this episode,  Stefanie Houseknecht, PharmD, BCOP (Johns Hopkins Medicine) and Monica Chintapenta, PharmD, BCOP (Parkland Health)share how they're navigating real-world use of lorlatinib, from interpreting long-term data to counseling patients through CNS effects, weight gain, and metabolic challenges.Highlights:Why lorlatinib is gaining traction in first-line ALK+ NSCLCWhat the long-term CROWN data really means for patient outcomesHow to handle tricky side effects like cognitive changes, weight gain, and hyperlipidemiaReal-world tips for patient counseling and supporting adherenceThe importance of catching drug interactions and staying ahead on labsHow pharmacists are shaping care across the oncology teamBonus: Hear how our guests find balance beyond the clinic, whether in the garden or on the Boston marathon course. About Our Guests:Monica completed her Doctor of Pharmacy at Texas Tech University Health Sciences Center and went on to complete PGY-1 and PGY-2 residencies at Tufts Medical Center and Froedtert & the Medical College of Wisconsin, respectively. At Parkland, she supports outpatient hematology/oncology care and leads quality initiatives.   Stefanie earned her PharmD from the University of the Pacific, followed by PGY-1 and PGY-2 residencies at Palomar Medical Center and the University of California-San Diego. Her work focuses on thoracic malignancies, access to oral targeted therapies, and patient outcomes. She is active in the International Association for the Study of Lung Cancer and serves as a preceptor to pharmacy trainees across the Mid-Atlantic.  

When Madison Marsh stepped into the spotlight as Miss America 2024, she brought more than just a crown—she brought a mission. In this episode of the PQI Podcast, Madison shares the deeply personal story behind her advocacy for cancer awareness and early detection. A Harvard student,  founder of the Whitney Marsh Foundation, and first active duty military member to be crowned Miss America, she is turning personal loss into powerful change—and inspiring others to do the same.Following her keynote at the NCODA Spring Forum, Madison opens up about how losing her mother to pancreatic cancer at a young age became the catalyst for her work. She founded the Whitney Marsh Foundation to drive progress in early detection, research, and education. Now pursuing a Master in Public Policy at Harvard, her focus is on improving access to care and exploring the role of artificial intelligence in transforming cancer diagnostics.Madison reflects on her journey through service, science, and pageantry—and how each part of her path fuels her mission to advocate for others. She reminds us that regardless of background or title, everyone has the power to lead, inspire, and work toward better healthcare outcomes.

As bispecific therapies become more available in the outpatient setting, community oncology practices are adapting to support safe and effective treatment.In this CE episode, we sit down with Nick Bouchard, PharmD, Director of Pharmacy Services at Hematology Oncology Associates of Central New York (HOACNY), to explore how his team built a successful outpatient bispecific therapy program from the ground up.Nick offers real-world insight into how his community oncology practice is proactively managing side effects like CRS and ICANS, improving patient experiences, and reducing hospital admissions. From navigating flexible dosing schedules to coordinating across the care team, this episode highlights the strategies that are making a meaningful difference in patient-centered care.

In this episode, we're joined by Dave Hughes, PharmD, BCOP, MPH, Senior Medical Director at Pfizer, who shares his expertise on the clinical trial landscape. With years of experience in oncology research and clinical pharmacy, Dave breaks down the key phases of clinical trials—from early-stage safety assessments to confirming effectiveness in large populations. Understanding these phases is essential for anyone involved in the drug development process.Dave also delves into the growing role of real-world evidence, which offers valuable insights into how therapies perform in everyday clinical settings, complementing traditional clinical trial data. He discusses how FDA approval pathways, such as fast track, breakthrough therapy, and accelerated approval, are designed to expedite access to life-saving therapies.We also explore the future of clinical trials, from AI and machine learning's transformative impact on research to the evolving strategies that will shape patient care. Finally, Dave addresses the common misconception that clinical trials are only available as a last resort, emphasizing that they offer early access to cutting-edge treatments throughout a patient's journey. Disclaimer:The views and opinions expressed in this episode are solely those of our guest, Dave, and do not represent the official stance, policies, or views of Pfizer, NCODA, or any other organization. This discussion is for informational purposes only and should not be considered medical or regulatory advice. Always consult with regulatory authorities for official guidance.

Effective oncology care thrives on collaboration, and in this episode, we're joined by two trailblazing oncology nurses, Elizabeth Bettencourt, MSN, RN, OCN, and Mary Anderson, BSN, RN, OCN, who share their wealth of experience and passion for improving cancer care. Together, they introduce a newly developed Positive Quality Intervention (PQI) within the Oral Anticancer Medication (OAM) Care Compass—a collaborative resource created with the Oncology Nursing Society to enhance interprofessional teamwork and streamline oral anticancer medication workflows.Elizabeth and Mary take us inside the process of mapping oral oncolytic workflows, breaking down how this PQI can improve team-based care, patient adherence, and overall safety. More than just a structured approach, this initiative represents a commitment to ensuring that every patient receiving oral anticancer therapy is fully supported by a well-coordinated healthcare team.This episode goes beyond workflows and best practices—it's about the people behind the care. Elizabeth and Mary bring their deep understanding of oncology nursing to the conversation, shedding light on how interprofessional collaboration can truly transform patient outcomes. Whether you're a nurse, pharmacist, or part of the oncology care team, you'll walk away with both practical insights and a renewed appreciation for the dedication that fuels high-quality cancer care. Explore the Resources:Oral Anticancer Medication Patient Management Workflow Evaluation and Process Mapping PQIOAM Care Compass  About the Guests:Elizabeth Bettencourt, MSN, RN, OCNWith more than 30 years in oncology, Elizabeth has dedicated the last 13 years to creating a comprehensive oral oncolytic program at Palo Alto Medical Foundation/Sutter Health. Her program, which has touched countless lives, weaves together prescription processing, education, and ongoing patient monitoring to ensure the best possible outcomes for patients battling cancer. Elizabeth's approach is a testament to the power of creating systems that truly support both patients and the oncology care team.Mary Anderson, BSN, RN, OCNMary's 36 years in oncology nursing are defined by her commitment to improving patient care and safety. Her journey, shaped by the struggles she saw patients face with oral anticancer medications, led her to develop critical interprofessional processes to enhance adherence and care. Now serving as the Senior Manager of Nursing Initiatives at NCODA, Mary's mission is to equip oncology nurses with the tools and confidence they need to provide exceptional, compassionate care. Her passion for empowering others shines through in everything she does. 

How can we truly deliver patient-centered care without understanding our patients' cultural backgrounds?In this episode of The PQI Podcast, Kafilat Salawu, DNP, FNP-C, AOCNP, BCPA, nurse practitioner, and Founder of FIDES Health Advocates, shares powerful insights on culturally competent care in oncology. Drawing from her personal journey and over 15 years of experience, she provides valuable insights on how healthcare professionals can bridge communication gaps and enhance care coordination, ultimately making a meaningful impact on the lives of patients from diverse backgrounds.Kafilat highlights the role of multidisciplinary teams, health literacy, and patient advocacy in delivering more inclusive care. She also discusses how addressing implicit bias and strengthening communication can lead to better treatment experiences and outcomes for diverse patient populations.Continuing Education (CE) InformationThis episode is accredited for 0.5 CE credit for pharmacists and pharmacy technicians.Learning Objectives:Define culturally competent care and its impact on oncologyRecognize barriers to equitable care and strategies to overcome themDiscuss the role of implicit bias in healthcare and approaches to mitigate its effectsExplore how multidisciplinary teams and patient advocacy improve treatment outcomesTo claim CE credit, use the access code: 3S D2H H and submit here. About the GuestDr. Kafilat Salawu, DNP, FNP-BC, is a board-certified family nurse practitioner and founder of FIDES Health Advocates, dedicated to improving health equity through patient advocacy and education. With over 15 years in hematology and oncology, she is a leading voice in culturally competent care, empowering patients and providers to create more inclusive treatment experiences. Disclosures:The following relevant financial relationships within the past 24 months have been identified and disclosed for the reviewers of this CE presentation:Dr. Kafilat Salawu, DNP, FNP-C, AOCNP, BCPA – Consultant for BeiGene, with honoraria received.No relevant financial relationships for the following reviewers:Ginger Blackmon, PharmDTahsin Imam, PharmDDaisy Doan, PharmD  

In this episode of The PQI Podcast, we're excited to welcome Samira Daswani, founder and CEO of Manta Cares. As a cancer survivor, Samira knows firsthand the challenges of navigating the cancer journey. Driven by her own experience, she created Manta Cares to provide survivors and caregivers with tools that offer both practical support and peace of mind.We'll talk about how her personal story shaped the mission behind Manta Cares, including innovative resources like the Manta Planner and the unique subway-style maps that guide patients through the often-overwhelming process of cancer care.Samira is also the host of Patient from Hell, a top-ranked podcast on Spotify, where she shares powerful stories from the frontlines of patient advocacy, reminding us of all of the strength it takes to face the challenges of healthcare.Join us as we explore the intersection of personal experience, healthcare innovation, and the emotional challenges of cancer careLearn more at: MantaCares.com

For many cancer patients, the journey to treatment can be just as challenging as the treatment itself. What if that journey could be shortened—by bringing care directly to their homes?In this episode of the podcast, we're joined by Jennifer Hunsey, BSN, RN, Nursing Program Coordinator at Mayo Clinic Florida, to explore the innovative Cancer Care Beyond Walls initiative. This groundbreaking program is bringing oncology treatments directly to patients, minimizing barriers to care, and reducing the burden of travel. Jennifer discusses how the Mayo Clinic uses technology and a patient-centered approach to deliver chemotherapy and supportive care in the comfort of patients' homes.We learn the inspiration behind this initiative, the role of virtual oversight and home health nursing, as well as the challenges faced and the patient experiences that have shaped the program. Jennifer also shares exciting insights into future expansion plans that could reshape how cancer care is delivered.This episode offers a powerful look at the future of oncology care—listen now to discover the Cancer Care Beyond Walls program's impact on patients and the importance of expanding care beyond traditional settings.Jennifer Hunze, BSN, RN, the RN Program Coordinator for Mayo Clinic's Cancer Care Beyond Walls program. With over 20 years of nursing experience—17 of those in oncology—Jen has worked in various roles, including inpatient hematology, infusion nursing, and cancer treatment management. She now leads efforts to develop innovative cancer care delivery models aimed at improving access and the overall patient experience.

In celebration of International Women's Day, we're joined by Chara Reed, Senior Director of National Sales, who has spent over 30 years making an impact in pharmacy and healthcare. From her start as a pharmacy technician to leading in the specialty medication space, Chara has built a career centered on leadership, mentorship, and advocating for women in the field. As the founder of the Pharmacist Women Networking Association, she's dedicated to fostering connections and empowering the next generation of female leaders. Listen in as Chara shares insights on career growth, leadership, and the value of building a supportive professional network.Disclaimer: The views expressed by Chara Reed in this episode are her own and do not necessarily reflect those of her employer.

Staying connected during a health journey is essential for both patients and their loved ones. In this episode, we welcome Jay Drayer, founder of CareFlash, and Steven Paulson, MD, President and Chairman of Texas Oncology, to discuss how CareFlash communities provide a unique space for sharing updates, offering support, and easing the emotional challenges of caregiving.Jay founded CareFlash in 2005, inspired by his personal caregiving experiences. He brings a unique blend of financial expertise, strategic vision, and a deep passion for innovation to his work. Through platforms like Careopolis, Kiddopolis, and Petopolis, CareFlash helps families and loved ones navigate caregiving with empathy and connection.Dr. Paulson, a board-certified medical oncologist and hematologist, leads Texas Oncology, one of the largest cancer treatment organizations in the country. With a distinguished career spanning decades, he has been instrumental in advancing oncology care and ensuring patients receive cutting-edge treatments in a compassionate, community-based setting.Together, Jay and Dr. Paulson share insights into the role of connection in patient care, how CareFlash enhances communication among caregivers, and what excites Dr. Paulson about the future of oncology.For more information on CareFlash, visit CareFlash.com.

Ilana Graetz, PhD, is an Associate Professor at Emory University's Rollins School of Public Health and leader of the Cancer Prevention and Control Research Program at the Winship Cancer Institute. Dr. Graetz's research centers on leveraging health information technology to transform care delivery and improve patient outcomes. As the principal investigator and co-investigator on numerous federally and institutionally funded studies, her work encompasses a wide range of topics, including data analytics, the use of electronic health records and patient portals to enhance care quality and coordination, telehealth innovations, remote monitoring, and patient-reported outcomes. She also leads efforts to design and evaluate mobile health interventions that strengthen patient-provider communication, support treatment adherence, and improve health outcomes.

In this premiere episode, Jessica White, PharmD, VP of Speciality Portfolio & Programs at McKesson, brings over 20 years of experience to the table. From managing oncology's generics portfolio to fostering manufacturer relationships, Jessica shares her unique insights into the strategies that can help navigate drug shortages and ensure continuity in patient care.Tune in as Jessica emphasizes the importance of collaboration among stakeholders to maintain supply chain stability and deliver exceptional care.Check out Jessica's article, Stakeholders Collaborate to Ensure Supply Chain Continuity, where she discusses how effective collaboration can help prevent drug shortages and maintain continuous patient care.

In this special bonus episode of the PQI Podcast, we're celebrating NCODA's own Sharita Howe, Associate Director of Partner Development and Strategy, and a 2025 MM+M 40 Under 40 honoree.Sharita takes us through her career journey, from her early days as a retail pharmacist to her current leadership role at NCODA, where she's driving meaningful changes in oncology care through collaboration and patient-centered initiatives. She reflects on how her experiences have shaped her path, the significance of her recent recognition, and the growing role of pharmacists in oncology.Sharita's career is a powerful example of the impact pharmacists can have, not just behind the counter but as leaders in transforming patient care. Tune in for an inspiring conversation on how collaboration, leadership, and education are driving change in oncology care. Plus, we couldn't resist asking—what's Sharita planning to wear on the red carpet?

In this special holiday episode, they're looking back on 2024's highlights, sharing their personal journeys that led to NCODA, and looking ahead to all the exciting possibilities in 2025. Get ready for some holiday cheer with Christmas trivia, spirited cookie debates, and heartwarming stories about why NCODA's mission continues to inspire.

Cindy and John explore the unique challenges veterans face, especially in rural areas, and explore innovative solutions like telehealth, coordinated care, and public-private partnerships aimed at improving care quality and access for this deserving population.Tune in for this impactful conclusion to Season 7, where we honor the service of our veterans and those who dedicate their lives to their care. Thank you for joining us this season, and stay tuned for more inspiring conversations in Season 8!Additional Resources:Veteran Patient Cancer Care

In this episode, you'll hear from veterans who have carried invaluable life lessons from their military service into healthcare, where they're now transforming patient care in oncology. From time in uniform to impactful roles in clinical pharmacy, nursing, and healthcare management, these incredible guests share how their experiences have shaped their personal and professional journeys.Join us for an uplifting conversation that honors our heroes in healthcare as they continue their mission of service in communities across the country.Featured Guests:Chris Saenz, PharmD | Clinical Pharmacy Specialist, Memorial Hermann Health SystemRyan Blackmon, RN | Chemo Infusion Nurse, Mayo Clinic FloridaJay Moore | Director, Market Access Southeast Region, Taiho Oncology, Inc.Victoria Eno | Marketing Manager, NCODAGayle Thompson, PharmD, MBA | Director of Pharmacy Operations, Duly Health and CareRobert D. Orzechowski, MBA, SPHR, SHRM-SCP | Chief Operating Officer, Lancaster Cancer Center, Ltd. (retired)

On this week's episode of the PQI Podcast, we dive into the transformative world of stem cell transplantation with David Samuel, PharmD, a dedicated Stem Cell Transplant Clinical Pharmacist at Texas Oncology in Dallas.David shares his inspiring journey through oncology pharmacy and offers a unique glimpse into his pivotal role in supporting outpatient stem cell transplant recipients and CAR-T cell therapy patients. He also highlights the vital patient education initiatives at Texas Oncology's Bone Marrow Transplant program, emphasizing the human connection that underpins effective oncology care.Tune in for an insightful conversation that highlights the vital role clinical pharmacists play in not just delivering care but also in empowering patients through their oncology journeys.

Chaunte is a four-time Olympian, world champion, and the American record-holder in the high jump, known for her groundbreaking achievements in track and field. Chaunte's journey took a life-altering turn in 2019 with a breast cancer diagnosis. Refusing to let this define her, Chaunte continued training throughout surgeries and chemotherapy, determined to maintain her strength and focus. Her story became more than an athletic legacy—it transformed into a mission to raise awareness for breast cancer and emphasize the importance of early detection.

He shares insights into the power of Next-Generation Sequencing (NGS) reports and the crucial data points that drive personalized therapies.We also dive into the growing role of pharmacists in precision medicine, including Dr. Knepper's contributions to the molecular tumor board.Links Mentioned:OncoKBcBioPortalClinVar

With a special focus on desmoid tumors, he dives into the latest treatment advancements and their implications for patient outcomes. Dr. Philip brings a wealth of expertise, having served with organizations such as the American Society of Clinical Oncology, the Connective Tissue Oncology Society, and the American College of Physicians.As an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip has a solid foundation in hematology and oncology, having completed his fellowship at North Shore-LIJ. His robust background in sarcoma management positions him to provide valuable perspectives on improving patient care in this complex field. 

In this episode, Nancy highlights the emotional and mental toll of her cancer journey, emphasizing how the psychological impact often outweighed the physical challenges. She discusses her role as a Peer Support Volunteer with NMDP (Be the Match), where she guides other AML patients through their treatment experiences and shares her insights as both a patient and an advocate.Nancy also previews her upcoming presentation at NCODA's Fall Summit, where she will delve into the importance of integrating mental health care into oncology support systems. She offers practical resources and discusses her upcoming blog for the Target Cancer Foundation, which further explores these critical themes.Tune in to hear Nancy's powerful story and insights on improving the mental health experience for cancer patients. This special episode is available on all major streaming platforms.

The episode kicks off with a playful game called “Drug or Gibberish,” where Ginger tests her skills in identifying real medications versus made-up names, with each correct guess leading to a donation to the National Marrow Donor Program. Together, Pat and Ginger explore how the show has transformed into a vital resource for sharing knowledge and experiences within the oncology community, celebrating its recent nomination for the MM+M Award in the Use of Podcasting category. They discuss the importance of diverse topics, consistent content, and the connections fostered through interviews with industry experts.Tune in to discover insights from Ginger's journey, the evolution of the podcast, and how you can leverage its resources to enhance your understanding of oncology practice.

In addition to her academic role, Dr. Ononogbu serves as a Board-Certified Hematology/Oncology Clinical Pharmacy Specialist at a Comprehensive Sickle Cell Center, where she provides specialized care and treatment for complex patient cases. Her clinical practice informs her research and offers practical solutions to improve patient outcomes in SCD care.Dr. Ononogbu is also deeply committed to mentoring future pharmacy leaders. She co-founded Pharmacy Initiative Leaders (PILs), a non-profit organization that helps pharmacy students secure post-doctoral residencies and fellowships, with a special emphasis on promoting diversity within the pharmacy workforce. A strong advocate for diversity, equity, and inclusion (DEI) in healthcare, Dr. Ononogbu is dedicated to ensuring equitable access to quality care, improving patient-provider communication, and fostering cultural competency in clinical settings. Her work continues to shape the future of pharmacy and improve care for those affected by sickle cell disease.Today's podcast is available to pharmacists and pharmacy technicians for CE credit and is worth 0.5 credits.To register for CE credit, please visit:https://www.lecturepanda.com/r/SCDOnDemand The objectives of today's podcast are:Discuss Sickle Cell Disease including pathophysiology as well as the history and timeline of SCD treatment.Interpret current challenges in SCD management and practical strategies to help improve care. Onye has no relevant financial relationships to disclose.

In this heartfelt episode, we talk with Alyssa Wakeley, a breast cancer survivor and the founder of Warriors That Pray. Diagnosed with breast cancer at just 27, Alyssa's powerful story is one of resilience, faith, and a deep sense of purpose. Her journey led to the creation of Warriors That Pray, a community centered on hope and support, where individuals navigating their own battles are uplifted and celebrated through meaningful jewelry. Alyssa shares her personal cancer experience, how she turned her adversity into a mission, and the role Warriors That Pray play in empowering others. This conversation dives into the impact of finding community, embracing your story, and holding on to hope through tangible reminders. You'll be inspired by Alyssa's unwavering strength and the beautiful message behind her organization. Discover more about Warriors That Pray at warriorsthatpray.com and connect with Alyssa on Instagram @warriorsthatpray. 

Dr. Toby Campbell is a Professor of Medicine, a Thoracic Oncologist, and Chief of Palliative Care. He holds the Ellen and Peter O. Johnson Chair in Palliative Care at the University of Wisconsin-Madison. Renowned for his expertise in handling complex conversations—such as delivering bad news, conducting family meetings, and managing high-risk decisions—he shares valuable insights from his extensive research and clinical practice. His multidisciplinary work has been published in top medical, surgical, and communication journals. Dr. Campbell's compassionate patient care has earned him several prestigious humanism awards from institutions, including the University of Virginia, the University of Wisconsin, and Northwestern University.

In this episode, Jordan Scott, PharmD, from Roswell Park Comprehensive Cancer Center, shares insights into the latest advancements in CAR T-cell therapy for Multiple Myeloma.This week's episode offers pharmacists the opportunity to earn 0.5 CE credit hours while exploring the newly expanded scope of CAR T-cell therapy and novel toxicities associated with specific CAR-T products. Learn effective management strategies for these toxicities and enhance patient outcomes in your practice.Jordan earned his Doctor of Pharmacy degree from D'Youville University in 2021. He completed his PGY1 Pharmacy residency training at Buffalo General Medical Center and PGY2 Oncology Pharmacy residency training at Roswell Park Comprehensive Cancer. His areas of practice include lymphoma, multiple myeloma, and transplant/cellular therapies. He is involved in direct patient care, collaborative practice, precepting, teaching, and research. Jordan is an avid football fan, cheering on the home team in Buffalo. Go Bills!To register for CE credit, please visit: https://www.lecturepanda.com/r/CARTOnDemandJordan has no relevant financial relationships to disclose. 

In this episode, we're joined by Dr. Oluwadamilola "Lola" Fayanju, a leader in breast cancer care and health equity. With a remarkable background that spans clinical excellence and innovative research, Dr. Fayanju holds the Helen O. Dickens Presidential Associate Professorship at the University of Pennsylvania (PENN) and serves as Chief of Breast Surgery at Penn Medicine. She also leads as the Surgical Director of the Rena Rowan Breast Center, directs Health Equity Innovation at the Penn Center for Cancer Care Innovation, and is a Senior Fellow at the Leonard Davis Institute of Health Economics.

Nutrition plays a pivotal role in cancer care, impacting treatment outcomes, recovery, and overall quality of life. In this episode, we explore this essential connection with Maggie Green, RDN, LD—a culinary dietitian, cookbook author, and host of the Cookbook Love Podcast. Maggie discusses how a proper diet can support cancer treatment and enhance patient well-being. She also shares insights from her experiences as a cookbook author and coach, offering valuable advice on bringing culinary ideas to life. Tune in to discover how nutrition and food can profoundly influence health and healing. You can find information on The Academy of Nutrition and Dietetics here. Learn more about Maggie here. Find her cookbooks at the links below:Kentucky Fresh CookbookTasting Kentucky: Favorite Recipes from the Bluegrass StateEssential Pantry: Streamline Your Ingredients, Simplify Your MealsEssential Plant-Based Pantry: Streamline Your Ingredients, Simplify Your Meals

New treatments and managing side effects are key challenges in kidney cancer care. In our latest episode of The PQI Podcast, we team up with the Kidney Cancer Association, Emily Wang, PharmD, BCOP, from MD Anderson, and Julia Stevens, PharmD, BCOP, from Beth Israel Deaconess, to share valuable insights into the newest advancements in kidney cancer therapies and practical strategies for managing side effects from TKI and IO treatments. Listen now to gain valuable knowledge that can transform your patient care approach.Learn more about the Kidney Cancer Association here. 

Welcome to the Season 7 premiere of The PQI Podcast! We're thrilled to kick off this new season by exploring the evolving role of the medically integrated team.In this episode, field experts Ben Harkness (Director of IT, Utah Cancer Specialists) and Mark Moch (CIO, American Oncology Network) share how cutting-edge cybersecurity strategies reshape healthcare. Gain valuable insights into proactive measures to safeguard patient data and the vital collaboration between IT and healthcare professionals. Don't miss these essential tips to keep your practice ahead of emerging challenges and enhance your security systems.

Welcome to The PQI Podcast season 6 finale! As we close out this chapter, we reflect on the survivor stories shared, the clinical insights gained, and the impactful conversations we've had over the last few months. We are thrilled to end this season with special guest Hardeep Phull, MD, to discuss various oncology hot topics, including burnout, financial toxicity, AI, and remaining current with literature.Dr. Phull is the Director of Oncology at Palomar Health, the Alumni Specialty Director at the Cleveland Clinic Lerner College of Medicine, and a Clinical Instructor at the University of California San Diego. He views his ongoing journey in medicine as a series of experiences that have enabled him to appreciate different values, cultures, and viewpoints, keeping him grounded and highly involved in education, mentorship, leadership, and advocacy in the community.You can find articles from Dr. Phull in NCODA's Oncolytics Today here:• The Mental Health Epidemic in Oncologists• Effect of Prior Authorization Rule Remains to be Seen

On this week's episode of The PQI Podcast, we sit down with Jerad Rex Davis. Despite his battle with Hodgkin's Lymphoma, Jerad, an attorney and musician from Western North Carolina, found solace in his music. His album "The Chemo Tapes," blends Americana, bluegrass, and folk, reflecting his resilience and unwavering spirit. Listen in as we explore Jerad's uplifting story, a testament to the healing power of music and the human spirit.You can find more information and Jerad's music here.

On this week's episode of The PQI Podcast, we put a spotlight on the recent 2024 NCODA International Spring Forum. The meeting brought together hundreds of NCODA members and partners with the shared goal of improving patient care.Listen in as we hear from several clinical and industry experts who participated in the Forum, sharing their insights and highlights from this inspiring gathering of oncology professionals.Thank you to all Spring Forum participants for your dedication and support! Save the date for the 2024 NCODA International Fall Summit, which will be held in Orlando, FL, on October 23 - 25.Testimonials:John Zieger, Bristol Myers SquibbTodd Knepper, PharmD, Moffitt Cancer CenterJordan Scott, PharmD, Roswell ParkApril Hallatt, BSN, RN, OCN, Indiana University Health Ball Memorial HospitalEmily Zimdars, CPhT and Jean Meyer, CPhT, M Health Fairview

This week, we sit down with Layla Van Doren, MD, MBA, and Kristen Boykin, PharmD, BCOP, BCPS, to discuss IV iron therapy. Dr. Van Doren is a hematologist with Yale New Haven Health and Director of Education in the Adult Sickle Cell Program. Kristen is the Director of Pharmacy Operations at Florida Cancer Specialists and Research Institute.  This podcast episode is sponsored by Pharmacosmos Therapeutics Inc. Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit us at www.monoferric.com to learn more.

On this week's episode of The PQI Podcast, we sit down with Juline George, PharmD, and Sasha Watson, PharmD, to explore the significance of pharmacist collaboration in oncology and its impact on optimizing patient care.Discover how their partnership benefits patients, hear real-life examples of its positive impact, and gain valuable insights for fostering effective collaboration between medically integrated and specialty pharmacies in oncology care.Juline is a pharmacist specializing in complex drug therapy regimens within specialty disease states, including oncology, transplant, inflammatory conditions, and infectious disease with Walgreens Specialty Pharmacy.Sasha is an Outpatient Medical Oncology Clinical Pharmacist at the University of Miami Sylvester Comprehensive Cancer Center. She currently works with the GI and Sarcoma clinics at Sylvester.

In this week's episode of The PQI Podcast, we welcome Claire Kennedy, BSc (Hons), MAPharmT, and Chandra Maraj, BSc (Hons), MAPharmT, from Oxford University Hospitals NHS Foundation Trust. Joined by guest co-host Taryn Newsome, CPhT, Associate Manager of OPTA at NCODA, we dive into an engaging discussion on the evolving role of oncology pharmacy technicians in England.Claire, an Advanced Clinical Cancer Pharmacy Technician and Operational Manager, and Chandra, also an Advanced Clinical Cancer Pharmacy Technician and Cancer Pharmacy Manager at the same trust, are dedicated professionals passionate about advancing the career path and clinical role of Pharmacy Technicians in oncology.Chandra Maraj has devoted 14 years to the Cancer Pharmacy Team at Oxford University Hospitals NHS Foundation Trust. From being the sole full-time technician among three, the team has now grown to nearly 20 members.Throughout her tenure, Chandra has shaped technician roles and spearheaded the establishment of a new pharmacy service for cancer patients undergoing chemotherapy. Passionate about fostering learning and development, she aims to create a happier and healthier workplace for all pharmacy technicians.

This week, in recognition of Colorectal Cancer Awareness Month, we engage in a conversation with Dr. Robert Zaiden, MD, FACP, focusing on ctDNA testing in GI cancers and his team's contributions.Dr. Zaiden, a seasoned medical oncologist in Jacksonville, FL, specializing in GI/GU tumors, stands as one of the founding members of Baptist MD Anderson. His active participation and leadership in various committees, including the role of Physician-in-Chief and Head of Cancer Medicine ad interim, underscore his commitment to optimizing patient care. Serving as the current director of the GI Tumor board, he has been instrumental in the rapid growth of Baptist MD Anderson.With a wealth of experience, Dr. Zaiden has been a Principal Investigator or Sub-Investigator in over 20 clinical trials. Recognized with prestigious awards such as Physician of the Year and Teaching and Excellence awards, he is also the Medical Director of Infusion Centers at BMDA.Before joining Baptist Medical Center in 2015, Dr. Zaiden contributed to the Hematology/Oncology faculty at the University of Florida in Jacksonville. During his tenure at UF, he received the Outstanding Resident Teacher award and was consistently voted Exemplary Faculty Teacher for five consecutive years. Beyond his professional accomplishments, Dr. Zaiden actively promoted Colorectal and Prostate Cancer Screening awareness to underserved communities, delivering cancer awareness talks at the YMCA. He proudly received the WeCare Patient's Choice award in 2023.This episode is sponsored by Walgreens. Our expert oncology-specialized pharmacy team is here for you. Our patients are at the heart of what we do and our pharmacists offer expert and compassionate support throughout each patient's unique cancer journey. Let's work together to care for the whole patient. Click here to find a Walgreens oncology-specialized pharmacist near you.

This week, in honor of International Women's Day, we sit down with Shikha Jain, MD, FACP, to discuss Women in Medicine, an organization dedicated to empowering and supporting women professionals in the healthcare industry. Dr. Jain will not only enlighten us with insights into the inspiring work of Women in Medicine but also unveil some exciting developments in the realm of GI oncology. Plus, she shares her secrets to effective patient-doctor communication, ensuring every individual receives top-notch care.Dr. Jain is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the Division of Hematology and Oncology at the University of Illinois in Chicago. She is the Director of Communications Strategies in Medicine and the Associate Director of Oncology Communication and Digital Innovation for the University of Illinois Cancer Center.  Dr. Jain is the Founder and Chair of the Women in Medicine Summit™ as well as the Founder and Board Member of the 501©(3) nonprofit Women in Medicine™. She is also the CEO and Co-Founder of the action, advocacy and amplification 501©(3) nonprofit IMPACT and was named one of Medscapes 25 Rising Stars in Medicine in 2020, one of Modern Healthcare's Top 25 Emerging Leaders in 2019 and was also awarded the Rising Star award by LEAD Oncology in 2019. She is also a member of the prestigious AOA society.  In her clinical practice as an oncologist, she tries to incorporate patient education and outreach as often as possible. With the proper tools and guidance, she works with her patients as a team to treat the disease and helps them move through an often difficult process together with as little stress as possible. She believes in personalized and individualized care and feels the more knowledge a patient has about their own disease, the more informed a decision they are able to make.The email addresses discussed in the podcast are:wimnfp@gmail.comwimsummit2019@gmail.com Twitter: @ShikhaJainMDInstagram: @ShikhaJainMDwww.shikhajainmd.comwww.womeninmedicinesummit.orgwww.impact4hc.com

On this week's episode of The PQI Podcast, we welcome the dynamic duo from Central Ohio Urology Group, Melanie Boren MHA, RN, BSN, OCN, and Robin Carr. Join us as they delve into how their multidisciplinary team collaborates to deliver top-tier patient care.Melanie is the Director of Oncology Operations at Central Ohio Urology Group.  She has worked in the oncology setting for 25 years. Robin is the Lead Pharmacy Tech at Central Ohio Urology Group. She oversees all dispensing of medications at two locations and has been a Pharmacy Technician for 35 years. 

On this week's episode of The PQI Podcast, we sit down with Alex Shantiai, PharmD, to discuss the dynamic realm of pharmaceutical careers and highlights NCODA's Professional Student Organization (PSO). As an oncology health and science representative and a leader within PSO, Alex shares insights on diverse pharmacist career paths in the industry, recounting his journey from pharmacy school to pharmaceutical sales.Alex is a Palm Beach Atlantic University graduate who currently works as an oncology health and science representative for a pharmaceutical company. Alex continues engagement, communication, and philanthropy for the benefit of pharmacists, pharmacy technicians, and students. He works with national committees among the American Pharmacists Association and Kappa Psi Pharmaceutical Fraternity, as well regional affiliations. He also serves as a board of director member with the international Phi Kappa Phi Honor Society.You can find more information on NCODA's PSO here:https://www.ncoda.org/professional-student-organizations/

This week, we sit down with Julie Kennerly-Shah, PharmD, MS, MHA, BCPS, to discuss the Ohio State Wexner Medical Center's Drug Repository Program.Julie is an associate director in the Department of Pharmacy and is responsible for hematology/oncology, pain/palliative and ambulatory care clinical services in The James Cancer Hospital. She oversees our state-of-the-art specialty retail pharmacies. In addition to her clinical and operational responsibilities, she facilitates the Hematology/Oncology Pharmacy and Therapeutics Committee and has administrative responsibility for the PGY2 Hematology/Oncology Residency Program.She earned her Doctor of Pharmacy from the University of North Carolina at Chapel Hill and earned dual master degrees from The Ohio State University in the areas of health system pharmacy administration and health care administration. She completed a combined PGY1 and PGY2 Health System Pharmacy Administration Residency at The Ohio State University Wexner Medical Center and completed the Oncology Administration Fellowship at The James Cancer Hospital.Julie and her husband founded the Summit and Julie Shah Foundation, where they are “On a mission to help the least fortunate in our world and to inspire others to join.” More information on their foundation can be found here: https://www.shahfound.org. 

This week we sit down with Jennifer Young Pierce, MD, MPH, FACOG to discuss her role, disparities in cervical cancer, and exciting advancements in her space. Dr. Jennifer Young Pierce is a Senior Staff Physician and Professor of Gynecologic Oncology at the University of South Alabama Mitchell Cancer Institute (MCI). She joined USA Health MCI in 2017 with national expertise in Human Papillomavirus (HPV), cervical cancer, and cancer disparities. She currently serves as the Division Director of Cancer Prevention and Control and an Abraham A. Mitchell Clinical Cancer Research Scholar.She is also the host of the podcast, The Cancering Show, seeking to demystify cancer with knowledge, hope, and humor for thousands of listeners. Most importantly, Dr. Pierce is deeply committed to the care of women with gynecologic cancers and spends the majority of her time seeing patients and performing radical surgeries for cancer treatment.  Dr. Pierce lives with her husband and two daughters in Mobile, Alabama.You can find more information on The Cancering Show here: https://cancering.com/

On this week's episode of The PQI Podcast, we sit down with Renee Alsarraf, DVM, DACVIM, to discuss her inspiring journey detailed in the acclaimed book Sit, Stay, Heal: What Dogs Can Teach Us About Living Well, where she intertwines her experiences as a veterinary oncologist and her personal battle with cancer.Dr. Alsarraf received her veterinary degree from Michigan State University. She completed an internship and oncology residency at the Animal Medical Center in NYC. Currently, she is a Senior Veterinarian at the Animal Medical Center in NYC.Sit, Stay, Heal is a moving and uplifting memoir of an esteemed veterinary oncologist fighting to save her four-legged patients while making sense of her own unexpected cancer diagnosis.

On this week's episode of The PQI Podcast, we sit down with Makenna Smack, PharmD, BCOP, from MD Anderson, to discuss molecular testing and targeted treatment in colorectal cancer. Makenna obtained her bachelor's in biochemistry from Brigham Young University and Doctor of Pharmacy from Roseman University in South Jordan, Utah. After graduation, she completed her PGY1 pharmacy residency at Memorial Hermann Hospital System in Houston, Texas, and a PGY2 oncology residency at Boston Medical Center in Massachusetts.She is board-certified by the Board of Pharmacy Specialties in Oncology Pharmacy. Makenna currently works in the Gastrointestinal (GI) Medical Oncology Clinic at MD Anderson. In this role, she is part of the multidisciplinary team overseeing the care of patients with colon, rectal, hepatobiliary, neuroendocrine, pancreatic, hepatic, and upper GI cancers. Makenna is passionate about providing effective patient education, adverse event management, and supportive care for her oncology patients. Outside of work, Makenna enjoys the snowless winters in Houston, trying new restaurants, and going to the park with her husband and son.

The PQI Podcast is back, and season 6 is here to ignite your passion for patients! NCODA is thrilled to bring you another season that promises insights, inspiration, and a prescription for innovation in the field of oncology. Our season premiere features Dr. Richard Safeer, Chief Medical Director of Employee Health and Well-Being for Johns Hopkins Medicine. A true expert in cultivating a healthy and resilient workforce, Dr. Safeer will guide us through his book, "A Cure for the Common Company: A Well-Being Prescription for a Happier, Healthier, and More Resilient Workforce." Listeners will be empowered with practical tools to not only build a thriving workplace but one that flourishes.In January 2023, with publisher Wiley, Dr. Safeer released A Cure for the Common Company: A Well-Being Prescription for a Happier, Healthier, and More Resilient Workforce. Dr Safeer is the first author to provide a step-by-step roadmap for creating a well-being culture that integrates science with practical solutions as demonstrated by the numerous real stories from successful companies. He is a fellow of the American Academy of Family Medicine, the American College of Lifestyle Medicine, and the American College of Preventive Medicine. He serves on the New England Journal of Medicine Catalyst Insight Council and previously served on the board of directors for the American College of Lifestyle Medicine.You can learn more about Richard's work at RichardSafeer.com or follow him on LinkedIn.If you're looking for training on how to create a wellbeing culture on your team or organization, then go to CreatingAWellbeingCulture.com A Cure for the Common Company: A Well-Being Prescription for a Happier, Healthier, and More Resilient Workforce is available on Amazon and wherever books are sold.

This week, on The PQI Podcast season 5 finale, we sit down with  Ellen J. Langer, Ph.D., to discuss her most recent book, THE MINDFUL BODY: Thinking Our Way to Chronic Health, and her mindfulness work in oncology.Dr. Langer was the first woman to be tenured in psychology at Harvard, where she is still professor of psychology. The recipient of three Distinguished Scientists awards, the Arthur W. Staats Award for Unifying Psychology, a Guggenheim Fellowship, and the Liberty Science Genius Award, Dr. Langer is the author of twelve other books, including the international bestseller Mindfulness, as well as The Power of Mindful Learning, Counterclockwise and On Becoming an Artist. Her trailblazing experiments in social psychology have earned her inclusion in The New York Times Magazine's “Year in Ideas” issue. She is known worldwide as the “mother of mindfulness” and the “mother of positive psychology.”

This week, we sit down with Erica Kirschner and Jenn Perry to discuss Li-Fraumeni Syndrome and the Li-Fraumeni Syndrome Association.Erica is a former educator who has been undergoing treatment for metastatic breast cancer for the past eleven years. After being diagnosed at 27, she was referred for genetic testing and found to have Li-Fraumeni Syndrome. LFS is a hereditary TP53 variant that predisposes children and adults to a wide array of cancers. She currently works with the nonprofit Li-Fraumeni Syndrome Association as a patient advocate.Jenn is a breast cancer survivor who was diagnosed with Li-Fraumeni syndrome. She is the President of the Li-Fraumeni Syndrome Association. Through the association, Jenn knew she had finally found an avenue to make a difference and effect change in an area that has affected not only many members of her family but many families around the world. She envisions a world someday where her children, grandchildren, and future family won't have to live in fear of the disease we know as cancer.You can find more information on the Li-Fraumeni Syndrome Association here:https://www.lfsassociation.org/